Ultrahypofractionated Radiotherapy for Localised Prostate Cancer: How Far Can We Go?

Corkum, M T; Achard, V; Morton, G; Zilli, T

Corkum, M T; Achard, V; Morton, G; Zilli, T.

Afiliación

Corkum MT; Division of Radiation Oncology, Department of Radiology, The Ottawa Hospital, Ottawa, Ontario, Canada.
Achard V; Division of Radiation Oncology, Department of Oncology, Geneva University Hospitals and Faculty of Medicine, Geneva University, Geneva, Switzerland.
Morton G; Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Zilli T; Division of Radiation Oncology, Department of Oncology, Geneva University Hospitals and Faculty of Medicine, Geneva University, Geneva, Switzerland. Electronic address: Thomas.Zilli@hcuge.ch.

Clin Oncol (R Coll Radiol) ; 34(5): 340-349, 2022 05.

Article en En | MEDLINE | ID: mdl-34961659

Asunto(s)

Braquiterapia; Neoplasias de la Próstata; Radiocirugia; Humanos; Masculino; Neoplasias de la Próstata/radioterapia; Hipofraccionamiento de la Dosis de Radiación

Palabras clave

Dose fractionation; high dose rate brachytherapy; prostate cancer; stereotactic body radiotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Braquiterapia / Radiocirugia Tipo de estudio: Guideline Límite: Humans / Male Idioma: En Revista: Clin Oncol (R Coll Radiol) Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google